<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Hum Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">36103875</article-id>
      <article-id pub-id-type="pmc">9606381</article-id>
      <article-id pub-id-type="pii">S0002-9297(22)00362-7</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2022.08.010</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>GABBR1</italic> monoallelic <italic>de novo</italic> variants linked to neurodevelopmental delay and epilepsy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="au1">
          <name>
            <surname>Cediel</surname>
            <given-names>Maria Lucia</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">8</xref>
        </contrib>
        <contrib contrib-type="author" id="au2">
          <name>
            <surname>Stawarski</surname>
            <given-names>Michal</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">8</xref>
        </contrib>
        <contrib contrib-type="author" id="au3">
          <name>
            <surname>Blanc</surname>
            <given-names>Xavier</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author" id="au4">
          <name>
            <surname>Noskov&#xE1;</surname>
            <given-names>Lenka</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author" id="au5">
          <name>
            <surname>Magner</surname>
            <given-names>Martin</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author" id="au6">
          <name>
            <surname>Platzer</surname>
            <given-names>Konrad</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author" id="au7">
          <name>
            <surname>Gburek-Augustat</surname>
            <given-names>Janina</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author" id="au8">
          <name>
            <surname>Baldridge</surname>
            <given-names>Dustin</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author" id="au9">
          <name>
            <surname>Constantino</surname>
            <given-names>John N.</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author" id="au10">
          <name>
            <surname>Ranza</surname>
            <given-names>Emmanuelle</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn2" ref-type="fn">9</xref>
          <xref rid="fn3" ref-type="fn">10</xref>
        </contrib>
        <contrib contrib-type="author" id="au11">
          <name>
            <surname>Bettler</surname>
            <given-names>Bernhard</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn2" ref-type="fn">9</xref>
          <xref rid="fn3" ref-type="fn">10</xref>
        </contrib>
        <contrib contrib-type="author" id="au12">
          <name>
            <surname>Antonarakis</surname>
            <given-names>Stylianos E.</given-names>
          </name>
          <email>stylianos.antonarakis@medigenome.ch</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn2" ref-type="fn">9</xref>
          <xref rid="fn3" ref-type="fn">10</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Medigenome, Swiss Institute of Genomic Medicine, 1207 Geneva, Switzerland</aff>
        <aff id="aff2"><label>2</label>Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50/70, 4056 Basel, Switzerland</aff>
        <aff id="aff3"><label>3</label>Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic</aff>
        <aff id="aff4"><label>4</label>Department of Pediatrics, First Faculty of Medicine, Charles University and University Thomayer Hospital in Prague, Prague, Czech Republic</aff>
        <aff id="aff5"><label>5</label>Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany</aff>
        <aff id="aff6"><label>6</label>Division of Neuropaediatrics, Hospital for Children and Adolescents, University Hospital Leipzig, Leipzig, Germany</aff>
        <aff id="aff7"><label>7</label>Washington University in St. Louis, St. Louis, MO, USA</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>stylianos.antonarakis@medigenome.ch</email></corresp>
        <fn id="fn1">
          <label>8</label>
          <p id="ntpara0010">These authors contributed equally</p>
        </fn>
        <fn id="fn2">
          <label>9</label>
          <p id="ntpara0015">These authors contributed equally</p>
        </fn>
        <fn id="fn3">
          <label>10</label>
          <p id="ntpara0020">Joint last authors</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>06</day>
        <month>10</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>9</month>
        <year>2022</year>
      </pub-date>
      <volume>109</volume>
      <issue>10</issue>
      <fpage>1885</fpage>
      <lpage>1893</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>3</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>8</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2022 American Society of Human Genetics.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>American Society of Human Genetics</copyright-holder>
      </permissions>
      <abstract id="abs0010">
        <title>Summary</title>
        <p>GABA<sub>B</sub> receptors are obligatory heterodimers responsible for prolonged neuronal inhibition in the central nervous system. The two receptor subunits are encoded by <italic>GABBR1</italic> and <italic>GABBR2</italic>. Variants in <italic>GABBR2</italic> have been associated with a Rett-like phenotype (MIM: <ext-link ext-link-type="omim" xlink:href="617903" id="intref0010">617903</ext-link>), epileptic encephalopathy (MIM: <ext-link ext-link-type="omim" xlink:href="617904" id="intref0015">617904</ext-link>), and milder forms of developmental delay with absence epilepsy. To date, however, no phenotypes associated with pathogenic variants of <italic>GABBR1</italic> have been established. Through GeneMatcher, we have ascertained four individuals who each have a monoallelic <italic>GABBR1 de novo</italic> non-synonymous variant; these individuals exhibit motor and/or language delay, ranging from mild to severe, and in one case, epilepsy. Further phenotypic features include varying degrees of intellectual disability, learning difficulties, autism, ADHD, ODD, sleep disorders, and muscular hypotonia. We functionally characterized the four <italic>de novo GABBR1</italic> variants, p.Glu368Asp, p.Ala397Val, p.Ala535Thr, and p.Gly673Asp, in transfected HEK293 cells. GABA fails to efficiently activate the variant receptors, most likely leading to an increase in the excitation/inhibition balance in the central nervous system. Variant p.Gly673Asp in transmembrane domain 3 (TMD3) renders the receptor completely inactive, consistent with failure of the receptor to reach the cell surface. p.Glu368Asp is located near the orthosteric binding site and reduces GABA potency and efficacy at the receptor. GABA exhibits normal potency but decreased efficacy at the p.Ala397Val and p.Ala535Thr variants. Functional characterization of <italic>GABBR1</italic>-related variants provides a rationale for understanding the severity of disease phenotypes and points to possible therapeutic strategies.</p>
      </abstract>
      <abstract abstract-type="teaser" id="abs0015">
        <p>Pathogenic mutations in the human gene GABBR1 (encoding a protein that forms a receptor in neuronal cells) cause a rare autosomal dominant disorder with neurodevelopmental delay and epilepsy. These findings are important for diagnosis and genetic counseling; in addition, they provide the opportunity for development of new therapies.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>gene</kwd>
        <kwd>mendelian disease</kwd>
        <kwd>GABBR1</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: September 13, 2022</p>
    </notes>
  </front>
</article>
</pmc-articleset>